newsfilter
← Latest News
GlobeNewswire·

Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365

MANCHESTER, N.H. and GERMANTOWN, Md., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Sequel Med Tech, LLC, a company developing transformative drug delivery technologies, and Senseonics Holdings, Inc. (NASDAQ:SENS), a medical